Señales en vivo de 0IRF.IL | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (6 may 2024 @ 14:14):

Stats
Volumen de hoy	66 600.00
Volumen promedio	337 165
Capitalización de mercado	1.71B
EPS	€-0.220 ( 2023-09-30 )
Last Dividend	€0 ( N/A )
Next Dividend	€0 ( N/A )
P/E	-16.62
ATR14	€0.0350 (0.37%)

Volumen Correlación

Largo: -0.20 (neutral)

Corto: -0.66 (moderate negative)

Signal:(46.48) Neutral

Evotec SE Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Evotec SE Correlación - Moneda/Commodity

0.56
( weak )

0.60
( weak )

0.00
( neutral )

-0.28
( neutral )

-0.61
( weak negative )

Evotec SE Finanzas

Annual	2022
Ingresos:	€751.45M
Beneficio Bruto:	€174.07M (23.16 %)
EPS:	€-0.990

FY	2022
Ingresos:	€751.45M
Beneficio Bruto:	€174.07M (23.16 %)
EPS:	€-0.990

FY	2021
Ingresos:	€618.03M
Beneficio Bruto:	€151.54M (24.52 %)
EPS:	€1.300

FY	2020
Ingresos:	€500.92M
Beneficio Bruto:	€125.74M (25.10 %)
EPS:	€0.0400

Financial Reports:

No articles found.

Evotec SE

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer AG; Lilly; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.